Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Basic pathogenetic mechanisms in silicosis: current understanding.

Binaya Rimal1, Alissa K Greenberg, William N Rom

  • 1Division of Pulmonary and Critical Care Medicine, NYU School of Medicine, New York, New York 10016, USA.

Current Opinion in Pulmonary Medicine
|February 9, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Annals of Education: Teaching Climate Change and Global Public Health.

International journal of environmental research and public health·2024
Same author

A New Model of Learning: Environmental Health in a Global World.

International journal of environmental research and public health·2023
Same author

Ethical thinking in occupational and environmental medicine: Commentaries from the Selikoff Fund for Occupational and Environmental Cancer Research.

American journal of industrial medicine·2022
Same author

Lower Airway Dysbiosis Affects Lung Cancer Progression.

Cancer discovery·2020
Same author

Value of metalloproteinases in predicting COPD in heavy urban smokers.

Respiratory research·2020
Same author

A Gene Expression Classifier from Whole Blood Distinguishes Benign from Malignant Lung Nodules Detected by Low-Dose CT.

Cancer research·2018
Same journal

Nonsteroid treatment options in (pulmonary) sarcoidosis. When to consider and why?

Current opinion in pulmonary medicine·2026
Same journal

Multidisciplinary approach in cardiac sarcoidosis: to biopsy or not?

Current opinion in pulmonary medicine·2026
Same journal

Low diffusion capacity in pulmonary hypertension.

Current opinion in pulmonary medicine·2026
Same journal

Toward precision imaging in interstitial lung disease: advances in quantitative imaging and artificial intelligence.

Current opinion in pulmonary medicine·2026
Same journal

Oxygen therapy in interstitial lung disease - navigating benefit and burden.

Current opinion in pulmonary medicine·2026
Same journal

Preclinical and clinical advances in pulmonary hypertension associated with systemic sclerosis.

Current opinion in pulmonary medicine·2026
See all related articles

Silicosis, a lung disease, is driven by silica particle interactions with lung cells. Understanding these molecular mechanisms is key to developing new treatments for this condition.

Area of Science:

  • Pulmonary Medicine
  • Toxicology
  • Cellular and Molecular Biology

Background:

  • Silicosis remains a significant cause of chronic lung disease, despite preventable origins.
  • Key cellular and molecular mechanisms driving silicosis pathogenesis are not fully understood.

Purpose of the Study:

  • To review recent research on the cellular and molecular mechanisms of silicosis.
  • To identify potential therapeutic targets for silicosis treatment.

Main Methods:

  • Review of in vivo, in vitro, and human studies.
  • Focus on silica particle properties, macrophage activation, and cellular responses.

Main Results:

  • Silica particle surface triggers adverse reactions, including reactive oxygen and nitrogen species (ROS/RNS) generation.

Related Experiment Videos

  • Activated alveolar macrophages and their products contribute to silicosis development and progression.
  • Silica-induced oxidants lead to cell damage, inflammation (TNF-alpha, IL-1 beta, TGF-beta), and apoptosis.

    • Conclusions:

    • Further research into inflammatory molecular mechanisms is crucial for effective silicosis treatment.
    • Potential therapies include cytokine inhibition (IL-1, TNF alpha), antioxidants, and apoptosis inhibitors.